Patients Sponsored A prevention healthcare revolution: The future of pharma While rapid positive advances in medical science roll out, global healthcare systems still face an important opportunity for transformation: a prevention healthcare revolution.
R&D When is the superbug message going to bite? As existing antibiotics become less effective, we edge closer to a future where routine infections & minor injuries could once again become high risk.
Patients BIO 2025: Planning, not panic, as BIO weighs in on US vaccin... At BIO 2025, vaccines were top of mind as a result of recent actions by HHS. Speakers addressed news head on, but also explored the larger context.
News UK to start "world first" gonorrhoea vaccine programme As infections rise, a world-first gonorrhoea vaccine programme has been launched in the UK.
News Experts deplore Trump's order for US to exit from WHO One of the first acts of President Donald Trump after his inauguration yesterday was to order the start of the US's withdrawal from the WHO.
News New drugs 'benefit patients, but maybe not populations' The money spent by the NHS on newly approved therapies recommended by NICE might have been better spent elsewhere, according to a new study.
News Lundbeck preps for key bexicaserin data around year-end Lundbeck has completed patient randomisation in a pivotal trial of epilepsy candidate bexicaserin, one of its major growth hopes.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.